The HER2/neu (c-erbB-2) proto-oncogene is a transmembrane receptor tyrosine kinase that is clinically indicated in a number of carcinomas. Overexpression of the c-erbB-2 protein has been associated with ductal breast cancer, as well as pulmonary and gastric adenocarcinomas. A correlation between HER2 and p53 has also been documented, as overexpression of both proteins has been associated with early invasion and metastasis in bladder cancer.

• IHC042-Her2 Datasheet-IVD

• MSDS
• GeneAb™ IHC Antibodies ranked Optimal by NordiQC
• 2021 NordiQC Assessment Report for IHC042: Optimal

CLONE:
IHC042

ISOTYPE:
IgG2a

HOST SPECIES:
Mouse

CLONALITY:
Monoclonal

POSITIVE CONTROL:
Breast Carcinoma

DILUTION RANGE:


INTENDED USE/REG. STATUS:
IVD

ADDITIONAL INFORMATION:
NordiQC Rating: Optimal
(Assessment Run B31 2021)